Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

by | May 12, 2026 | Clinical Trials | 0 comments

​ Conditions: Clonal Cytopenia of Undetermined Significance; Myelodysplastic Syndrome

Interventions: Drug: Nicotinamide Riboside; Drug: Pterostilbene

Sponsors: University of Colorado, Denver; Cancer League of Colorado

Not yet recruiting Conditions: Clonal Cytopenia of Undetermined Significance; Myelodysplastic Syndrome
Interventions: Drug: Nicotinamide Riboside; Drug: Pterostilbene
Sponsors: University of Colorado, Denver; Cancer League of Colorado
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *